Morgan Keegan Lowers PT on Athenahealth to $68

Symbols: ATHN
Share

Morgan Keegan has lowered the price target on Athenahealth (NASDAQ: ATHN) from $70 to $68 and maintains its Outperform rating.


 
 
< Previous
Miller Tabak Upgrades Buffalo Wild Wings to Buy
Next >
Societe Generale Downgrades Accenture to Sell
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust